20/20 Biolabs Inc. (AIDX) vs Ernexa Therapeutics Inc. (ERNA)

A side-by-side comparison of 20/20 Biolabs Inc. and Ernexa Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.35HealthcareDelayed quote: Oct 6, 2026, 1:02 PM EDT
Ernexa Therapeutics Inc. logo
ERNA
Ernexa Therapeutics Inc.
$4M
$2.35HealthcareDelayed quote: Oct 6, 2026, 1:03 PM EDT

Total return — AIDX vs ERNA

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)ERNA -66.8% (-66.8%/yr)ERNA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$33
AIDX ERNA

AIDX vs ERNA: by the numbers

  • •AIDX is the larger company ($4M vs $4M market cap).
  • •Both run net losses; ERNA's is the smaller (0.00% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXERNA
P/S ratio2.07N/A
P/B ratio2.611.20

Profitability

MetricAIDXERNA
Gross margin31.52%0.00%
Operating margin-162.87%0.00%
Net margin-285.00%0.00%
ROE-184.04%-383.03%
ROIC-116.89%-346.94%

Growth (annualized)

MetricAIDXERNA
Revenue CAGR (5Y)-2.58%N/A
Total return CAGR (5Y)N/A-86.83%

Go deeper

Full AIDX analysisFull ERNA analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEErnexa Therapeutics ROE20/20 Biolabs operating marginErnexa Therapeutics operating margin20/20 Biolabs revenue growthErnexa Therapeutics revenue growth20/20 Biolabs free cash flowErnexa Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.